Autolus Therapeutics Presents Initial AUTO3 Clinical Data from Phase 1/2 Clinical Trials in B cell Malignancies at the 60th ASH Annual Meeting

Sunday, December 2, 2018 Clinical Trials News
Email Print This Page Comment bookmark
Font : A-A+

- Initial results were presented from ongoing Phase 1/2 trials in pediatric acute lymphoblastic leukemia (AMELIA trial) and diffuse B cell lymphoma (ALEXANDER trial) -

Investor Contact:

International Media Contact:

U.S. Media Contact:

S.A. Noonan Communications

JW Communications

Rx Communications Group, LLC

Susan A. Noonan

Julia Wilson

Melody Carey

+1-212-966-3650

+44 (0)7818 430877

+ 1-917-322-2571

susan@sanoonan.com

juliawilsonuk@gmail.com

mcarey@rxir.com



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store